IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced a reverse stock split of its issued and outstanding common stock, par ...

Find the latest historical data for Imunon, Inc. Common Stock (IMNN) at Nasdaq.com. View historical data in a monthly, bi-annual, or yearly format.